Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia	Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus	Recruiting	Phase 3	2026-01-15		NCT06772168

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CMG Pharmaceutical Co. Ltd	1

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ajou University Hospital	Suwon	South Korea	40
Buchon sejong hospital	Buchon	South Korea	1
Bundang CHA medical center	Seongnam	South Korea	1
Chonbuk National University Hospital	Jeonju	South Korea	2
Chosun University Hospital	Gwangju	South Korea	18
Daejeon Eulji Medical Center, Eulji University	Daejeon	South Korea	6
Hallym university gangnam medical center	Seoul	South Korea	1
Hallym university sungsim medical center	Anyang	South Korea	1
Hanyang University Medical Center	Guri-si	South Korea	1
Inha university hospital	Inchon	South Korea	1
Inje university heaundea paik hospital	Busan	South Korea	1
Keimyung University Dongsan Medical Center	Daegu	South Korea	9
Korea University Anam Hospital	Seoul	South Korea	94
Korea University Guro Hospital	Seoul	South Korea	83
Kyung Hee University Hospital at Gangdong	Seoul	South Korea	20
Myongji Hospital	Goyang-si	South Korea	3
Nowon Eulji Medical Center, Eulji University	Seoul	South Korea	2
Seoul National University Bundang Hospital	Seongnam	South Korea	56
Severance Hospital	Seoul	South Korea	81
Soonchunhyang cheonan university hospital	Cheonan	South Korea	1
The Catholic University of Korea, Seoul St. Mary's Hospital	Seoul	South Korea	47
Wonju serverance christian hospital	Wŏnju	South Korea	1
Wonkwang University Hospital	Iksan	South Korea	3
Yongin Severance Hospital	Yongin-si	South Korea	5

Clinical trials